As GRPs in cancer cells are conducive to malignant growth, the EMT and maintenance of cancer cell stemness and tumor chemo- and radioresistance (see Figure 5), some GRP-targeting agents are thought to be potentially applicable for repressing and sensitizing malignancies [142,236]. The gene discussed is GRP; the disease is cancer.